Thursday, March 15, 2007

Sleeping Pill Fact

"Sales in the United States of Ambien and Lunesta alone last year exceeded $3 billion. Use of those medications and other similar drugs has soared by more than 60 percent since 2000, fueled by television, print and other advertising. Last year, makers of sleeping pills spent more than $600 million on advertising aimed at consumers."

-F.D.A. Warns of Sleeping Pills’ Strange Effects

Related;
Listen to the background report on the story from NYT
FDA Requests Label Change for All Sleep Disorder Drug Products
"In December 2006, FDA sent letters to manufacturers of products approved for the treatment of sleep disorders requesting that the whole class of drugs revise product labeling to include warnings about the following potential adverse events:

-Anaphylaxis (severe allergic reaction) and angioedema (severe facial swelling), which can occur as early as the first time the product is taken.
-Complex sleep-related behaviors which may include sleep-driving, making phone calls, and preparing and eating food (while asleep).

The Zyprexa story (podcast)
Pharmaceutical company Eli Lilly (makers of Prozac) have agreed to pay upwards of 1.2 billion US dollars to nearly 30,000 patients who claim their bestseller antipsychotic medication, Zyprexa (Olanzapine) has resulted in diabetes, weight gain and other complications and that these risks were downplayed. Secret documents are leaked, the newspaper headlines start screaming, and citizen journalists spread the word - but where is the real advocacy for better drugs with fewer side effects?

No comments: